Senores Pharmaceuticals Ltd. (IN:SENORES)
:SENORES
Want to see IN:SENORES full AI Analyst Report?
Summary of all the Indicators
Overall Consensus
Buy
12Bullish
6Neutral
4Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Senores Pharmaceuticals Ltd.’s (SENORES) Moving Averages Convergence Divergence (MACD) indicator is 73.46, suggesting Senores Pharmaceuticals Ltd. is a Sell.
Senores Pharmaceuticals Ltd.’s (SENORES) 20-Day exponential moving average is 1202.43, while Senores Pharmaceuticals Ltd.’s (SENORES) share price is ₹716.9, making it a Buy.
Senores Pharmaceuticals Ltd.’s (SENORES) 50-Day exponential moving average is 1081.04, while Senores Pharmaceuticals Ltd.’s (SENORES) share price is ₹716.9, making it a Buy.
Senores Pharmaceuticals Ltd. (SENORES) Pivot Points
Classic
1,185.82
1,228.83
1,252.37
1,295.38
1,318.92
1,361.93
1,385.47
Fibonacci
1,228.83
1,254.26
1,269.96
1,295.38
1,320.81
1,336.51
1,361.93
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Senores Pharmaceuticals Ltd. (SENORES) Moving Averages
MA5
1,288.15Sell
1,277.97Sell
MA10
1,285.48Sell
1,257.44Buy
MA20
1,178.75Buy
1,202.43Buy
MA50
1,054.54Buy
1,081.04Buy
MA100
917.08Buy
974.57Buy
MA200
842.71Buy
871.28Buy
Senores Pharmaceuticals Ltd.’s (SENORES) 10-Day exponential moving average is 1257.44, while Senores Pharmaceuticals Ltd.’s (SENORES) share price is ₹716.9, making it a Buy.
Senores Pharmaceuticals Ltd.’s (SENORES) 100-Day exponential moving average is 974.57, while Senores Pharmaceuticals Ltd.’s (SENORES) share price is ₹716.9, making it a Buy.
Senores Pharmaceuticals Ltd.’s (SENORES) stock price is ₹716.9 and Senores Pharmaceuticals Ltd.’s (SENORES) 50-day simple moving average is 1054.54, creating a Buy signal.
Senores Pharmaceuticals Ltd.’s (SENORES) stock price is ₹716.9 and Senores Pharmaceuticals Ltd.’s (SENORES) 100-day simple moving average is 917.08, creating a Buy signal.
Senores Pharmaceuticals Ltd.’s (SENORES) stock price is ₹716.9 and Senores Pharmaceuticals Ltd.’s (SENORES) 200-day simple moving average is 842.71, creating a Buy signal.
Senores Pharmaceuticals Ltd. (SENORES) Technical Indicators
RSI (14)
64.59
Neutral
STOCH (9,6)
47.37
Neutral
STOCHRSI (14)
77.96
Neutral
MACD (12,26)
73.46
Sell
ADX (14)
42.12
Neutral
Williams %R
-24.49
Buy
CCI (14)
60.21
Neutral
ATR (14)
58.64
-
Ultimate Oscillator
37.08
Neutral
ROC
22.63
Buy
Senores Pharmaceuticals Ltd.’s (SENORES) Relative Strength Index (RSI) is 64.59, creating a Neutral signal.
Senores Pharmaceuticals Ltd.’s (SENORES) Trend Strength Indicator (ADX) is 42.12, creating a Neutral signal.
Senores Pharmaceuticals Ltd.’s (SENORES) Commodity Channel Index (CCI) is 60.21, creating a Neutral signal.
Senores Pharmaceuticals Ltd.’s (SENORES) Price Rate of Change (ROC) is 22.63, creating a Buy signal.
FAQ
Is SENORES a Buy, Hold, or Sell?
Based on SENORES’s technical indicators, SENORES is a Buy.
What is SENORES’s RSI (14)?
SENORES’s RSI (14) is 64.59, which suggests SENORES is a Neutral.
What is SENORES’s MACD?
SENORES’s MACD is 73.46, which suggests SENORES is a Sell.
What is SENORES’s 5-day moving average?
SENORES’s 5-day moving average is 1288.15, which suggests SENORES is a Sell.
What is SENORES’s 20-day moving average?
SENORES 20-day moving average is 1178.75, which suggests SENORES is a Buy.
What is SENORES’s 50-day moving average?
SENORES’s 50-day moving average is 1054.54, which suggests SENORES is a Buy.
What is SENORES’s 200-day moving average?
SENORES’s 200-day moving average is 842.71, which suggests SENORES is a Buy.
What is SENORES’s Williams % R (14)?
SENORES’s Williams % R (14) is -24.49, which suggests SENORES is a Buy.
What is SENORES’s CCI (14)?
SENORES’s CCI (14) is 60.21, which suggests SENORES is a Neutral.
What is the share price of Senores Pharmaceuticals Ltd.?